Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 182   

Articles published

PFE 29.11 +0.51 (1.78%)
price chart
US court upholds patents on Pfizer's cancer drug
(Reuters) - A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said.
Related articles »  
Pfizer Approves $11B Stock Buyback; Reduces Hopes for AstraZeneca Bid
Pfizer Inc. (NYSE:PFE) offered to acquire AstraZeneca plc (ADR) (NYSE:AZN) (LON:AZN) for $119 billion. The British pharmaceutical company rejected the proposal for the second time citing the reason that it was inadequate, and it would dilute ...
Pfizer Announces Share Buyback, Shares Pop Up  Benzinga
Pfizer Announces It Will Buy Back $11 Billion in Shares  Bloomberg
Related articles »  
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?
Unfortunately, these figures imply that if Pfizer does not come back for Astra, Astra's shares will fall. If the company's valuation were to fall to a level similar to the rest of the sector, the shares would only be worth 3,523p. With earnings ...
Related articles »  
Pfizer Approves $11B Stock Repurchase Plan
Pfizer Inc. is the world's second-largest drugmaker, and its products include the vaccine Prevnar and pain and fibromyalgia treatment Lyrica.
What to look for in Pfizer earnings
Pfizer Inc. is scheduled to announce its third-quarter earnings Tuesday morning. Here's what you need to know: EARNINGS: Net income of 55 cents a share is the consensus of analysts surveyed by Thomson Reuters, compared with 58 cents reported during ...
Related articles »  
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Big Pharma is undergoing a radical face-lift due to the avalanche of top-selling drugs losing patent protection. The consequences of the aptly named "patent cliff" have been widespread and immense in scope.
Pfizer Inc. (PFE) Plans Quarterly Dividend of $0.26
Pfizer logo Pfizer (NYSE:PFE) declared a quarterly dividend on Thursday, October 23rd, AnalystRatings.NET reports. Stockholders of record on Friday, November 7th will be given a dividend of 0.26 per share on Tuesday, December 2nd.
Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid
Company Update (NYSE:PFE): Pfizer Declares 26-Cent Fourth-Quarter 2014 ...  Jutia Group
Related articles »  
Stocks to Watch: UPS, P&G, Amazon, Lear, Alcoa, Microsoft, Pfizer
United Parcel Service Inc. said its revenue rose 5.7% in the latest quarter, helped by higher daily package volumes and strength overseas.
Related articles »  
Should Pfizer Inc. Buy Actavis plc?
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer Inc. May Be Interested In Buying Actavis plc [REPORT]  ValueWalk
Pfizer Inc. Is Kicking The Tires At Actavis PLC  Benzinga
Related articles »  
Pfizer Approves $11 Bln Share Buyback, Dividend; Wins Sutent Patent Case
The company also said that a U.S. court has ruled in its favor in a patent lawsuit filed against generic drug maker Mylan Inc. ( MYL ) related to Pfizer's cancer drug Sutent. Pfizer's board authorized the new $11 billion share repurchase program to be ...